Canada: Lessons From GlaxoSmithKline’s Record $492 Million Bribery Fine In China

On September 19, 2014, pharmaceutical giant GlaxoSmithKline plc (GSK) announced that its Chinese subsidiary had been found guilty of bribing health officials in the country and was forced to swallow a 3 billion yuan ($492 million CDN) penalty, the largest corporate fine in China's history. Five of the company's managers were also given suspended prison sentences of two to four years' probation after the one-day trial in Hunan Province. GSK has announced that it is not seeking to appeal.

This bulletin will review what led to GSK's bitter medicine in China's courts and what lessons this example holds for other foreign companies operating in the country or trying to combat their own corruption risks more broadly.

"A Massive Bribery Network"

In June 2013, the Wall Street Journal reported that GSK was investigating allegations from an anonymous tipster that its sales staff engaged in widespread bribery to sell drugs between 2004 and 2010. According to the reports, employees of the company would often treat doctors and others to trips and pay their expenses. Yet after a four-month investigation, GSK announced that its internal probe found no evidence of corruption. Then, in May 2014, Chinese officials launched their own investigation after accusing Mark Reilly, GSK's manager in China, of operating "a massive bribery network" since 2009 by having his salespeople pay doctors and hospital officials bribes to boost GSK's drug sales. According to Chinese officials, these bribes resulted in several billion yuan in "illegal revenue" for the company, an amount commensurate with the fine levied against it. GSK announced it was cooperating with authorities in the investigation, which may account for the probation sentences being more lenient than may have otherwise been expected.

Though it may be too early to say what went wrong for GSK in China, what is known about this case and the corrective actions GSK has since announced it has taken, provide some key lessons for other companies trying to combat their corruption risk.

Understand the Shifting Landscape of Local Compliance Risks

For over 30 years, the United States, through the Foreign Corrupt Practices Act, was effectively the world's anti-corruption police. It was only four years ago that the United Kingdom joined the fray through its tough Bribery Act and Canada finally began to enforce its own Corruption of Foreign Public Officials Act. Yet even then there was often little incentive to comply with local anti-corruption laws in developing countries to the dearth of such prohibitions or their virtual non-enforcement.

This compliance risk is now changing. The fact that the Chinese have now levied a near half billion-dollar corruption fine against a foreign company, even before the Serious Fraud Office in the UK and the Department of Justice in the US concluded their own investigations, changes the risk calculus for corruption in China. Commercial bribery is a crime in China. However, its enforcement has not always been consistent. While there are complaints that some enforcements are selective, there are also reports that several other large pharmaceutical manufacturers are on the list of suspected investigations and have received uninvited visits by Chinese authorities. Foreign companies operating in China in other industries may now find local authorities emboldened to prosecute efforts to seek business advantages through illicit means.

This is also becoming ever more the case in Brazil under the recently enacted (and harsh) Clean Companies Law, in India under the new Lokpal Act and with the newly elected Prime Minister Modi's corruption crackdown, and in many other developing countries instituting and better enforcing their own anti-bribery scheme.

Constantly Monitor Internal Accounting Controls

In announcing its criminal fine, GSK admitted that the illegal activities of its subsidiary were "in clear breach" of its compliance systems and that it was "expanding processes for reviewing and monitoring of invoicing and payments." GSK's response underscores the fact that internal accounting controls are only as effective as a compliance tool to the extent that they are constantly audited through, ideally, a system of sophisticated data analytics and continuous monitoring. GSK would have had some systems in place to track expenditures and, presumably, required proper authorizations and documentation for larger outlays. However, those systems appear to have failed to properly detect potentially hundreds of millions of dollars worth of bribes, gifts and illicit expenses. While no internal control system is perfect, a more sophisticated data review process, tailored to specific red flags for bribes, may have detected problems earlier and avoided such a massive penalty.

Manage Employee Incentive Risk

Sales commissions and salaries tied to specific sales targets are a classic incentive risk for bribery by employees or contractors, especially in higher risk jurisdictions such as China. According to public reports, GSK's management adopted very aggressive sales tactics and incentive mechanisms which influenced the occurrence of the commercial bribes. Similar sales tactics are reported to have been used by some other pharmaceutical companies as well, but GSK was reviewed as one of the worst offenders. It has been reported that the training and remuneration systems of GSK and some other large pharmaceutical manufacturers have been significantly changed to mitigate such issues. Progressive companies have sought to manage these risks in a number of ways, including paying higher salaries to reduce the incentive to bribe, aggregating bonus structures or commissions over a longer period to provide more opportunities for compliance oversight, and providing 'compliance' bonuses.

GSK's problems in China exemplify the importance of properly managing internal employee incentive risk, as does the company's announcement that it is "decoupling sales targets from compensation" for its sales force. Other large pharmaceutical manufacturers are expected to follow suit.

Companies Need Clear Client Engagement Guidelines

Lastly, if reports are true that many of GSK's illicit activities were paid trips and expense reimbursements for doctors and other hospital officials through travel agencies and other intermediaries, this will be just the latest example of a "bribe by any other name." Gifts, entertainment and travel for public officials are prime targets of corruption probes given that anti-bribery legislation in Canada, the UK and US all prohibit the offer of a "benefit" to a public official, which need not be cash, in return for an improper business advantage for the offeror. We have previously provided guidance on gift giving in this context, but all companies should also have clear guidelines on entertainment, hospitality and travel when engaging clients, especially when those clients are public officials. It is also crucial to make sure these guidelines are understood and followed by intermediaries such as agents, consultants and the like.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.